Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05267340

Neural Mechanisms of Meditation Training in Healthy and Depressed Adolescents: An MRI Connectome Study PART 2

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
14 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The primary objective will be to study changes in putamen connectivity and depression severity in depressed teens with meditation training. H1: Putamen node strength will increase in the training group compared to the active controls. H2: This increase in node strength will correlate with practice amount recorded by participants. H3: There will be a significant reduction in self-rated depression symptoms following the training as measured by the Reynolds Adolescent Depression Scale (RADS-2), compared to controls. H4: This reduction will correlate with the increase in putamen node strength. Design and Outcomes: The current research study design will utilize an individually randomized group treatment, open-label, active-controlled clinical trial to test the efficacy and safety of the investigator's innovative mindfulness meditation intervention (Training for Awareness Resilience and Action \[TARA\]) on the primary outcome (Putamen structural node strength) and secondary outcome (depression symptoms measured using Reynolds Adolescent Depression Scale \[RADS-2\]) in depressed adolescents between the ages of 14 to 18 years old.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTARAThis will be a 12-week group meditation training - Training for Awareness, Resilience, and Action (TARA)
BEHAVIORALPsycho-EducationThis will be a 12-week group meditation training - Training for Awareness, Resilience, and Action (TARA) without the mindfulness meditation components

Timeline

Start date
2023-02-08
Primary completion
2026-08-31
Completion
2026-08-31
First posted
2022-03-04
Last updated
2026-03-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05267340. Inclusion in this directory is not an endorsement.